Market Overview

Lupin Says Received FDA Approval for Generic Lexapro

Related FRX
Activis Shares Languish Post-Forest Deal
Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 500
Forest Labs to Buy Furiex Pharma in $1.5B Deal (Fox Business)

Pharma major, Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Escitalopram Tablets (Escitalopram oxalate) 5 mg, 10 mg, and 20 mg, from the United States Food and Drugs Administration (FDA) to market a generic version of Forest Laboratories, Inc.'s (Forest) Lexapro Tablets, 5 mg, 10 mg, and 20 mg.

Posted-In: News FDA

 

Most Popular

Related Articles (FRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters